Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma / 전남의대학술지
Chonnam Medical Journal
; : 109-114, 2015.
Article
in En
| WPRIM
| ID: wpr-788322
Responsible library:
WPRO
ABSTRACT
The prognostic value of whole-body positron emission tomography/computed tomography (PET/CT) with 18F-fluoro-2-deoxy-D-glucose (FDG) shortly after the onset of induction chemotherapy or mid treatment could help to predict long-term clinical outcomes in patients with Hodgkin's or Non-Hodgkin's lymphoma. However, FDG is not a tumor-specific substance, and it may accumulate to the point of being detected in a variety of benign conditions or at physiologic anatomical sites, which may give rise to false-positive interpretation. In an attempt to standardize the reporting criteria for interim PET/CT, the First International Workshop on Interim PET in Lymphoma suggested visual response criteria with the Deauville five-point scale, and the standardized uptake value (SUV) has been investigated in comparison with this visual system. A quantitative approach using the measurement of maximal SUV (SUVmax) or the reduction rate of SUVmax (DeltaSUVmax) might be more appropriate in early-response PET/CT for reducing false-positive rates or for decreasing interobserver variability in interpretation. In this review, the predictive efficacy of PET/CT is discussed for the treatment of aggressive lymphoma, especially in terms of an interim PET/CT-based prognostic model.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Prognosis
/
Lymphoma, Non-Hodgkin
/
Observer Variation
/
Positron-Emission Tomography
/
Education
/
Electrons
/
Induction Chemotherapy
/
Positron Emission Tomography Computed Tomography
/
Lymphoma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Chonnam Medical Journal
Year:
2015
Type:
Article